Teva Pharmaceutical Industries Ltd Stock Ownership - Who owns Teva Pharmaceutical Industries?

Insider buying vs selling

Have Teva Pharmaceutical Industries Ltd insiders been buying or selling?
Richard DaniellExec. VP European Commercial2024-02-2820,599$13.12
Eric DrapeExecutive VP Global Operations2024-02-289,815$13.12
Vikki L. ConwaySee Remarks2024-02-281,366$13.12
Eric DrapeExecutive VP Global Operations2024-02-16173,261$13.06
Richard D. FrancisPresident and CEO2024-02-1574,530$13.15
Amir WeissChief Accounting Officer2024-02-0131,766$12.37
Eliyahu Sharon KalifEVP Chief Financial Officer2023-08-0735,125$9.73
Amir WeissChief Accounting Officer2023-08-041,981$9.92
Eric A. HughesSee Remarks2023-08-0152,742$8.30
Sven DethlefsEVP North America Commercial2023-03-0758,066$9.43

1 of 2

TEVA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TEVA insiders and whales buy or sell their stock.

TEVA Shareholders

What type of owners hold Teva Pharmaceutical Industries Ltd stock?
Blackrock Inc3.72%41,664,861$547.89MInstitution
Ion Asset Management Ltd3.60%40,327,407$530.31MInstitution
Lingotto Investment Management LLP3.07%34,457,656$453.12MInstitution
Phoenix Holdings Ltd3.07%34,383,192$452.14MInstitution
Clal Insurance Enterprises Holdings Ltd2.93%32,804,131$431.37MInstitution
Migdal Insurance Financial Holdings Ltd2.58%28,919,540$380.29MInstitution
Harel Insurance Investments Financial Services Ltd2.55%28,533,099$375.21MInstitution
Menora Mivtachim Holdings Ltd2.51%28,128,744$369.89MInstitution
Slate Path Capital LP2.34%26,231,184$344.94MInstitution
Rubric Capital Management LP1.63%18,226,601$239.68MInstitution

1 of 3

TEVA vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TEVA51.71%0.94%Net SellingNet Selling
VTRS80.69%17.85%Net SellingNet Selling
NBIX69.67%30.33%Net SellingNet Selling
CTLT79.66%20.34%Net BuyingNet Selling

Teva Pharmaceutical Industries Stock Ownership FAQ

Who owns Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries (NYSE: TEVA) is owned by 51.71% institutional shareholders, 0.94% Teva Pharmaceutical Industries insiders, and 47.36% retail investors. Blackrock Inc is the largest individual Teva Pharmaceutical Industries shareholder, owning 41.66M shares representing 3.72% of the company. Blackrock Inc's Teva Pharmaceutical Industries shares are currently valued at $562.48M.

If you're new to stock investing, here's how to buy Teva Pharmaceutical Industries stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.